Orphan drug grants

Executive Summary

FDA will award about 15 grants ranging from $20,000 to $100,000 in direct costs for up to three years to support clinical trials, according to an announcement in the Oct. 26 edition of the Federal Register. While some preliminary clinical research should already be available, the agency will consider drugs for which "persuasive pharmacologic evidence is available that a product has a reasonable possibility of being effective even though no clinical trials have been performed." Applications, which should be "for one discrete clinical trial," must be received by Jan. 25, 1988, with the earliest beginning date for awards July 1.